Tag: ChemDiv Inc News
Arcus Biosciences selects ChemDiv as Sole Chemistry Provider for its Discovery Screening Collection
SAN DIEGO, Calif. /California Newswire/ -- ChemDiv Inc., a fully integrated California-based CRO, announced today that Arcus Biosciences selected ChemDiv as the sole source of molecules for Arcus's growing HTS screening collection. This collaboration, which utilized Arcus's medicinal chemistry knowledge and ChemDiv's computational and synthetic chemistry expertise, has resulted in the selection of several hundred thousand structures from which Arcus expects to identify starting points for several of the discovery programs in its portfolio.